Thus, while MTTP inhibition clearly lowers plasma lipids and increases hepatic lipids, it is unclear how this hepatic steatosis is associated with or dissociated from a metabolically deleterious phenotype. The gene discussed is MT-TP; the disease is Hepatic steatosis.